ReviewFrontiers in aging neuroscience2025
A mini review of transforming dementia care in China with data-driven insights: overcoming diagnostic and time-delayed barriers.
Review in Frontiers in aging neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Inadequate primary care infrastructure and training in China and misconceptions about aging lead to high mis-/under-diagnoses and serious time delays for dementia patients, imposing significant burdens on family members and medical carers. Main body: A flowchart integrating rural and urban areas of China dementia care pathway is proposed, especially spotting the obstacles of mis/under-diagnoses and time delays that can be alleviated by data-driven computational strategies. Artificial intelligence (AI) and machine learning models built on dementia data are succinctly reviewed in terms of the roadmap of dementia care from home, community to hospital settings. Challenges and corresponding recommendations to clinical transformation are then reported from the viewpoint of diverse dementia data integrity and accessibility, as well as models' interpretability, reliability, and transparency. Discussion: Dementia cohort study along with developing a center-crossed dementia data platform in China should be strongly encouraged, also data should be publicly accessible where appropriate. Only be doing so can the challenges be overcome and can AI-enabled dementia research be enhanced, leading to an optimized pathway of dementia care in China. Future policy-guided cooperation between researchers and multi-stakeholders are urgently called for dementia 4E (early-screening, early-assessment, early-diagnosis, and early-intervention).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.